International Patent: PHARMACEUTICAL COMPOSITION COMPRISING RAMELTEON AND NASAL ADMINISTRATION FORMULATION

GENEVA, July 2 -- SHANGHAI ANBISON LAB CO., LTD. filed a patent application (CN2025/072097) for “PHARMACEUTICAL COMPOSITION COMPRISING RAMELTEON AND NASAL ADMINISTRATION FORMULATION”. With publication no. WO/2026/129450, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/343

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....